Table: begin end state 1 12 non-cytoplasmic 13 35 transmembrane 36 41 cytoplasmic 42 61 transmembrane 62 71 non-cytoplasmic 72 94 transmembrane 95 115 cytoplasmic 116 149 transmembrane 150 153 non-cytoplasmic 154 180 transmembrane 181 198 cytoplasmic 199 217 transmembrane 218 222 non-cytoplasmic 223 242 transmembrane 243 251 cytoplasmic 252 269 transmembrane 270 270 cytoplasmic 271 274 non-cytoplasmic 275 275 cytoplasmic 276 295 transmembrane 296 309 non-cytoplasmic 310 329 transmembrane 330 333 cytoplasmic 334 351 transmembrane 352 352 cytoplasmic 353 356 non-cytoplasmic 357 374 transmembrane 375 379 non-cytoplasmic 380 402 transmembrane 403 417 cytoplasmic 418 437 transmembrane 438 441 non-cytoplasmic 442 467 transmembrane 468 538 cytoplasmic 539 558 transmembrane 559 563 non-cytoplasmic
Input: >Pf1N1B4_1186 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_1186 MQTWQQLYSPLGSLGVSALAAVIPIVFFFLALAVFRLKGHVAGSITLALSIAVAIFAFQM PVDMAFAAAGYGFAYGLWPIAWIIVAAVFLYKLTVKSGQFEVIRSSVLSITDDQRLQVLL IGFCFGAFLEGAAGFGAPVAITAALLVGLGFNPLYAAGLCLIANTAPVAFGALGIPIIVA GQVTGIDAFKIGAMTGRQLPLLSLFVPFWLVFMMDGLRGVRETWPAALVAGLSFAITQYF TSNFIGPELPDITSALASLISLTLFLKIWQPKRAAGQHIVGAVSASVVSSAGGFGQPRTT VASPYSLGEIFKAWSPFLILTVLVTIWTLKPFKAMFAAGGSMYSWVFNFAIPHLDQMVIK VAPIVTAPTAIPAVFKLDPISATGTAIFFSALISMLVLKINLKIGLTTFKETVYELRWPI LSIGMVLAFAFVTNYSGMSSTMALVLAGTGAAFPFFSPFLGWLGVFLTGSDTSSNALFSS LQATTAHQIGVNDTLLVAANTSGGVTGKMISPQSIAVACAATGLVGKESDLFRFTLKHSL FFATIVGLITLAQAYWFTGMLVH
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server